|
Market Closed -
Nasdaq
23:00:00 02/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 3.900 USD | +3.72% |
|
0.00% | -6.25% |
Evolution of the Average Target: Galectin Therapeutics Inc.
Evolution of the Target Price: Galectin Therapeutics Inc.
Changes in Analyst Recommendations: Galectin Therapeutics Inc.
c474f9cbff51ec7bf2.kbVLjpZmk2ShEtoF5czgFeYesmPxxad3tkHpDZ6Fipg.2MQe4fw15jXycZlIqZ6RQpdq-jSXk-UP0gCBWPHa8_DJzw7G4F_gLPQjnw~586d54e6f253b1d5e8d0e519d955672e
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
 | - | - | +182.05% | |||
| +11.79% | |||||
| +27.75% | |||||
| +21.67% | |||||
| +24.6% | |||||
| +11.82% | |||||
| +21.07% | |||||
| +46.63% | |||||
| +6.77% | |||||
| +20.91% | |||||
| Average | +37.51% | |||||
| Weighted average by Cap. | +20.89% |
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
3.900USD
Average target price
11.00USD
Spread / Average Target
+182.05%
High Price Target
11.00USD
Spread / Highest target
+182.05%
Low Price Target
11.00USD
Spread / Lowest Target
+182.05%
Analyst Consensus Detail
Consensus revision (last 18 months)
- Stock Market
- Stocks
- GALT Stock
- Consensus Galectin Therapeutics Inc.
Select your edition
All financial news and data tailored to specific country editions
